DONATE

Free Support Line: 833-275-4222

Walk to End Bladder Cancer

Clinical Trials

A clinical trial is a research study that tries to find better ways to prevent, screen for, diagnose, or treat a disease like bladder cancer. 

Bladder cancer patients should talk with their healthcare team to determine whether a clinical trial is an option for their specific situation. They should carefully weigh the potential benefits and risks, ensuring they make an informed decision about their treatment plan.

Search for a clinical trial

You can search for a clinical trial below by bladder cancer disease state, state of residence and you can also look for trials nearest to you.

About Clinical Trials

✕To help find trials near you, you need to allow BCAN to access your location
Ok

Featured Trials
Title State Sponsoring Organization
A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC) New York Memorial Sloan Kettering Cancer Center
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer California University of California, San Francisco
sEphB4-HSA in EphrinB2-High Solid Tumors California Vasgene Therapeutics, Inc
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, the PARRC Trial Multi-State National Cancer Institute (NCI)
V940 and BCG in People With Bladder Cancer (V940-011/INTerpath-011) Multi-State Merck Sharp & Dohme LLC
Personalized Cancer Vaccine (PCV) Strategy in Patients with Solid Tumors and Molecular Residual Disease Missouri Washington University School of Medicine
Bladder Preservation for Patients with Muscle Invasive Bladder Cancer (MIBC) with Variant Histology California Leslie Ballas
PC14586 in Patients with Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) Multi-State PMV Pharmaceuticals, Inc
CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation Multi-State Clasp Therapeutics, Inc.
Title State Sponsoring Organization
A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC) New York Memorial Sloan Kettering Cancer Center
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer California University of California, San Francisco
sEphB4-HSA in EphrinB2-High Solid Tumors California Vasgene Therapeutics, Inc
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, the PARRC Trial Multi-State National Cancer Institute (NCI)
V940 and BCG in People With Bladder Cancer (V940-011/INTerpath-011) Multi-State Merck Sharp & Dohme LLC
Personalized Cancer Vaccine (PCV) Strategy in Patients with Solid Tumors and Molecular Residual Disease Missouri Washington University School of Medicine
Bladder Preservation for Patients with Muscle Invasive Bladder Cancer (MIBC) with Variant Histology California Leslie Ballas
PC14586 in Patients with Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) Multi-State PMV Pharmaceuticals, Inc
CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation Multi-State Clasp Therapeutics, Inc.

Learn more about the different phases clinical trials here.

This clinical trial dashboard would not be possible without the generous support of our corporate partners including, AstraZeneca, Bicycle Therapeutics, CG Oncology, Daiichi Sankyo, Ferring Pharmaceuticals, Fidia Farmaceutici, Flare Therapeutics, ImmunityBio, Johnson and Johnson, Lilly, Protara Therapeutics and Urogen.

Related Stories